<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03771755</url>
  </required_header>
  <id_info>
    <org_study_id>IndonesiaUAnes026</org_study_id>
    <nct_id>NCT03771755</nct_id>
  </id_info>
  <brief_title>Ibuprofen IV vs Acetaminophen IV for the Treatment of Pain Following Orthopaedic Low Extremity Surgery</brief_title>
  <official_title>A Prospective, Randomized, Double-blind Study Assessing the Efficacy of Intravenous (IV) Ibuprofen Versus IV Acetaminophen for the Treatment of Pain Following Orthopaedic Low Extremity Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the efficacy of IV Ibuprofen versus IV Acetaminophen in the
      reduction of pain following orthopedic low extremity procedures
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approval from Ethical Committee of Faculty of Medicine Universitas Indonesia was acquired
      prior conducting the study. Patients undergoing orthopedic low extremity surgery were
      screened. Eligible subjects were then randomized into treatment group (intravenous ibuprofen)
      and control group (intravenous acetaminophen). In case required, patients from both group
      will be given Morphine (PCA) 1-2 mg every 5 minutes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>24 hours</time_frame>
    <description>demonstrated by the measurement VAS (Visual Analog Scale) for 24 hrs postoperative.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Lower Extremity Problem</condition>
  <condition>Surgery</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Ibuprofen group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>800 mg IV - Ibuprofen every 6 hours. In case required - followed with Morphine (PCA) 1-2 mg every 5 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1000mg IV Acetaminophen every 6 hours. In case required - followed with Morphine (PCA) 1-2 mg every 5 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>800 mg IV - Ibuprofen every 6 hours. In case required - followed with Morphine (PCA) 1-2 mg every 5 minutes</description>
    <arm_group_label>Ibuprofen group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>1000mg IV Acetaminophen every 6 hours. In case required - followed with Morphine (PCA) 1-2 mg every 5 minutes</description>
    <arm_group_label>Acetaminophen group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for Orthopedic Low Extremity Surgery with general anesthesia and anticipated
             need post operative IV analgesia with anticipated use of &gt;48 hours.

          -  Adequate IV access.

          -  Anticipated hospital stay&gt;48 hours.

          -  Age 18-70 years old with physical status ASA I- III.

          -  Patients able to fill informed consent sheet.

        Exclusion Criteria:

          -  patients with use of analgesia, muscle relaxants, NSAIDs and sedatives less than 24
             hours to study drug administration

          -  anemia (active, clinically significant anemia) and/or a history or evidence of asthma
             or heart failure

          -  historical or at higher risk intracerebral bleeding, history of allergy or
             hypersensitive to NSAID, Ibuprofen, Acetaminophen or opioid

          -  pregnant or nursing

          -  body weight less than 30 kg

          -  any active clinically significant bleeding or have underlying platelet dysfunction
             and/or receiving full dose anticoagulation therapy

          -  GI bleeding that required medical intervention within the previous 6 weeks (unless
             definitive surgery has been performed)

          -  on dialysis or renal dysfunction

          -  impaired liver function

          -  inability to achieve hemostasis or inability to close surgical incision prior to
             operating room discharge

          -  operative procedure includes organ transplant, pre-and intra- operative procedure
             utilized for the prevention of pre- or post-operative pain (i.e, epidural or nerve
             blocks)

          -  received anoher investigational drug within the past 30 days

          -  known or suspected history of alcohol or drug abuse

          -  severe infection and/or inflammatory disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aida Tantri</last_name>
    <phone>+628161832487</phone>
    <email>aidatantri@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cipto Mangunkusumo Cental National Hospital</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aida R Tantri, Consultant</last_name>
      <phone>+628161832487</phone>
      <email>aidatantri@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <reference>
    <citation>Ip HY, Abrishami A, Peng PW, Wong J, Chung F. Predictors of postoperative pain and analgesic consumption: a qualitative systematic review. Anesthesiology. 2009 Sep;111(3):657-77. doi: 10.1097/ALN.0b013e3181aae87a. Review.</citation>
    <PMID>19672167</PMID>
  </reference>
  <reference>
    <citation>Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology. 2000 Oct;93(4):1123-33. Review.</citation>
    <PMID>11020770</PMID>
  </reference>
  <reference>
    <citation>Kehlet H, Holte K. Effect of postoperative analgesia on surgical outcome. Br J Anaesth. 2001 Jul;87(1):62-72. Review.</citation>
    <PMID>11460814</PMID>
  </reference>
  <reference>
    <citation>Shavit Y, Fridel K, Beilin B. Postoperative pain management and proinflammatory cytokines: animal and human studies. J Neuroimmune Pharmacol. 2006 Dec;1(4):443-51. Epub 2006 Sep 29. Review.</citation>
    <PMID>18040817</PMID>
  </reference>
  <reference>
    <citation>Beilin B, Shavit Y, Trabekin E, Mordashev B, Mayburd E, Zeidel A, Bessler H. The effects of postoperative pain management on immune response to surgery. Anesth Analg. 2003 Sep;97(3):822-7.</citation>
    <PMID>12933409</PMID>
  </reference>
  <reference>
    <citation>Hall GM, Peerbhoy D, Shenkin A, Parker CJ, Salmon P. Relationship of the functional recovery after hip arthroplasty to the neuroendocrine and inflammatory responses. Br J Anaesth. 2001 Oct;87(4):537-42.</citation>
    <PMID>11878721</PMID>
  </reference>
  <reference>
    <citation>Esme H, Kesli R, Apiliogullari B, Duran FM, Yoldas B. Effects of flurbiprofen on CRP, TNF-α, IL-6, and postoperative pain of thoracotomy. Int J Med Sci. 2011 Mar 10;8(3):216-21.</citation>
    <PMID>21448308</PMID>
  </reference>
  <reference>
    <citation>Dionne RA, Gordon SM, Rowan J, Kent A, Brahim JS. Dexamethasone suppresses peripheral prostanoid levels without analgesia in a clinical model of acute inflammation. J Oral Maxillofac Surg. 2003 Sep;61(9):997-1003.</citation>
    <PMID>12966473</PMID>
  </reference>
  <reference>
    <citation>Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000 Jul;85(1):109-17. Review.</citation>
    <PMID>10927999</PMID>
  </reference>
  <reference>
    <citation>Duggan ST, Scott LJ. Intravenous paracetamol (acetaminophen). Drugs. 2009;69(1):101-13. doi: 10.2165/00003495-200969010-00007. Review.</citation>
    <PMID>19192939</PMID>
  </reference>
  <reference>
    <citation>Glenn EM, Bowman BJ, Rohloff NA. Anti-inflammatory and PG inhibitory effects of phenacetin and acetaminophen. Agents Actions. 1977 Dec;7(5-6):513-6.</citation>
    <PMID>414527</PMID>
  </reference>
  <reference>
    <citation>Vinegar R, Truax JF, Selph JL. Quantitative comparison of the analgesic and anti-inflammatory activities of aspirin, phenacetin and acetaminophen in rodents. Eur J Pharmacol. 1976 May;37(1):23-30.</citation>
    <PMID>1278245</PMID>
  </reference>
  <reference>
    <citation>Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum. 2000 Feb;43(2):378-85.</citation>
    <PMID>10693878</PMID>
  </reference>
  <reference>
    <citation>Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med. 1991 Jul 11;325(2):87-91.</citation>
    <PMID>2052056</PMID>
  </reference>
  <reference>
    <citation>Bonnefont J, Courade JP, Alloui A, Eschalier A. [Antinociceptive mechanism of action of paracetamol]. Drugs. 2003;63 Spec No 2:1-4. Review. French.</citation>
    <PMID>14758785</PMID>
  </reference>
  <reference>
    <citation>Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther. 2005 Jan-Feb;12(1):46-55. Review.</citation>
    <PMID>15662292</PMID>
  </reference>
  <reference>
    <citation>Khan AA, Iadarola M, Yang HY, Dionne RA. Expression of COX-1 and COX-2 in a clinical model of acute inflammation. J Pain. 2007 Apr;8(4):349-54. Epub 2007 Jan 30.</citation>
    <PMID>17270500</PMID>
  </reference>
  <reference>
    <citation>Kashefi P, Honarmand A, Safavi M. Effects of preemptive analgesia with celecoxib or acetaminophen on postoperative pain relief following lower extremity orthopedic surgery. Adv Biomed Res. 2012;1:66. doi: 10.4103/2277-9175.100197. Epub 2012 Aug 28.</citation>
    <PMID>23459777</PMID>
  </reference>
  <reference>
    <citation>Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther. 2013;15 Suppl 3:S2. doi: 10.1186/ar4174. Epub 2013 Jul 24. Review.</citation>
    <PMID>24267197</PMID>
  </reference>
  <reference>
    <citation>Morris PE, Promes JT, Guntupalli KK, Wright PE, Arons MM. A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults. Crit Care. 2010;14(3):R125. doi: 10.1186/cc9089. Epub 2010 Jun 30.</citation>
    <PMID>20591173</PMID>
  </reference>
  <reference>
    <citation>Scott LJ. Intravenous ibuprofen: in adults for pain and fever. Drugs. 2012 May 28;72(8):1099-109. doi: 10.2165/11209470-000000000-00000.</citation>
    <PMID>22621696</PMID>
  </reference>
  <reference>
    <citation>Southworth S, Peters J, Rock A, Pavliv L. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Clin Ther. 2009 Sep;31(9):1922-35. doi: 10.1016/j.clinthera.2009.08.026.</citation>
    <PMID>19843482</PMID>
  </reference>
  <reference>
    <citation>Kroll PB, Meadows L, Rock A, Pavliv L. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen (i.v.-ibuprofen) in the management of postoperative pain following abdominal hysterectomy. Pain Pract. 2011 Jan-Feb;11(1):23-32. doi: 10.1111/j.1533-2500.2010.00402.x.</citation>
    <PMID>20642488</PMID>
  </reference>
  <reference>
    <citation>Singla N, Rock A, Pavliv L. A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen (IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients. Pain Med. 2010 Aug;11(8):1284-93. doi: 10.1111/j.1526-4637.2010.00896.x. Epub 2010 Jun 30.</citation>
    <PMID>20609131</PMID>
  </reference>
  <reference>
    <citation>Southworth SR, Woodward EJ, Peng A, Rock AD. An integrated safety analysis of intravenous ibuprofen (Caldolor(®)) in adults. J Pain Res. 2015 Oct 23;8:753-65. doi: 10.2147/JPR.S93547. eCollection 2015.</citation>
    <PMID>26604816</PMID>
  </reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>December 7, 2018</study_first_submitted>
  <study_first_submitted_qc>December 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2018</study_first_posted>
  <last_update_submitted>February 1, 2019</last_update_submitted>
  <last_update_submitted_qc>February 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Aida Rosita Tantri</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>ibuprofen</keyword>
  <keyword>acetaminophen</keyword>
  <keyword>orthopedic</keyword>
  <keyword>VAS</keyword>
  <keyword>morphine</keyword>
  <keyword>opioid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

